- Home
- CLGN vs FBIO Comparison
CLGN vs FBIO Comparison
Compare CLGN & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- FBIO
- Stock Information
- Founded
- CLGN 2004
- FBIO 2006
- Country
- CLGN Israel
- FBIO United States
- Employees
- CLGN N/A
- FBIO N/A
- Industry
- CLGN Industrial Specialties
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CLGN Health Care
- FBIO Health Care
- Exchange
- CLGN Nasdaq
- FBIO Nasdaq
- Market Cap
- CLGN 48.1M
- FBIO 39.4M
- IPO Year
- CLGN N/A
- FBIO N/A
- Fundamental
- Price
- CLGN $4.03
- FBIO $1.87
- Analyst Decision
- CLGN Strong Buy
- FBIO Strong Buy
- Analyst Count
- CLGN 2
- FBIO 3
- Target Price
- CLGN $12.50
- FBIO $18.00
- AVG Volume (30 Days)
- CLGN 12.0K
- FBIO 658.0K
- Earning Date
- CLGN 11-27-2024
- FBIO 11-14-2024
- Dividend Yield
- CLGN N/A
- FBIO N/A
- EPS Growth
- CLGN N/A
- FBIO N/A
- EPS
- CLGN N/A
- FBIO N/A
- Revenue
- CLGN $650,000.00
- FBIO $81,501,000.00
- Revenue This Year
- CLGN N/A
- FBIO N/A
- Revenue Next Year
- CLGN $692.59
- FBIO $128.63
- P/E Ratio
- CLGN N/A
- FBIO N/A
- Revenue Growth
- CLGN N/A
- FBIO 31.51
- 52 Week Low
- CLGN $3.24
- FBIO $1.36
- 52 Week High
- CLGN $6.75
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- CLGN 52.27
- FBIO 44.79
- Support Level
- CLGN $3.79
- FBIO $1.84
- Resistance Level
- CLGN $4.31
- FBIO $2.36
- Average True Range (ATR)
- CLGN 0.21
- FBIO 0.18
- MACD
- CLGN 0.02
- FBIO -0.03
- Stochastic Oscillator
- CLGN 54.89
- FBIO 5.77
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.